XML 47 R36.htm IDEA: XBRL DOCUMENT
v3.24.0.1

Stock-Based Compensation (Tables) | 9 Months Ended
--- | ---
Dec. 31, 2023
Equity [Abstract] |
Schedule of Repurchase Agreements | The following table summarizes total shares repurchased during the three and nine months ended December 31, 2023 and 2022:
| November 2020 Program |  | August 2022 Program |  | Total |  |  |  |
(In millions) | Shares |  | Amount |  | Shares |  | Amount(a) |  | Shares |  | Amount |  |  |  |  |  |  |  |
Three months ended December 31, 2023 | — |  |  | $ | — |  |  | 2.5 |  |  | $ | 325 |  |  | 2.5 |  |  | $ | 325 |  |  |  |  |  |  |  |  |
Nine months ended December 31, 2023 | — |  |  | $ | — |  |  | 7.6 |  |  | $ | 975 |  |  | 7.6 |  |  | $ | 975 |  |  |  |  |  |  |  |  |
Three months ended December 31, 2022 | — |  |  | $ | 5 |  |  | 2.6 |  |  | $ | 320 |  |  | 2.6 |  |  | $ | 325 |  |  |  |  |  |  |  |  |
Nine months ended December 31, 2022 | 5.1 |  | $ | 650 |  |  | 2.6 |  |  | $ | 320 |  |  | 7.7 |  |  | $ | 970 |  |  |  |  |  |  |  |  |
(a)Amount excludes excise taxes. Accrued excise taxes are included in accrued and other current liabilities and additional paid-in capital on the Condensed Consolidated Balance Sheets.
Disclosure Of Stock-Based Compensation Arrangements By Stock-Based Payment Award | The following table summarizes our stock option activity for the nine months ended December 31, 2023:
|  | Options (in thousands) |  | Weighted- Average Exercise Prices |  | Weighted- Average Remaining Contractual Term (in years) |  | Aggregate Intrinsic Value (in millions)
Outstanding as of March 31, 2023 |  | 121 |  |  | $ | 40.43 |  |  |  |  |
Granted |  | 2 |  |  | 128.90 |  |  |  |  |
Exercised |  | (90) |  |  | 39.28 |  |  |  |  |
Outstanding as of December 31, 2023 |  | 33 |  |  | $ | 50.31 |  |  | 2.62 |  | $ | 3 |
Vested and expected to vest |  | 33 |  |  | $ | 50.31 |  |  | 2.62 |  | $ | 3 |
Exercisable as of December 31, 2023 |  | 33 |  |  | $ | 50.31 |  |  | 2.62 |  | $ | 3 |
The following table summarizes our restricted stock units activity for the nine months ended December 31, 2023:
| Restricted Stock Units (in thousands) |  | Weighted- Average Grant Date Fair Values
Outstanding as of March 31, 2023 | 7,502 |  |  | $ | 128.54 |
Granted | 4,521 |  |  | 128.76 |
Vested | (3,668) |  |  | 130.08 |
Forfeited or cancelled | (664) |  |  | 129.56 |
Outstanding as of December 31, 2023 | 7,691 |  |  | $ | 127.85 |
The following table summarizes our performance-based restricted stock unit activity, presented with the maximum number of shares that could potentially vest, for the nine months ended December 31, 2023:
| Performance- Based Restricted Stock Units (in thousands) |  | Weighted- Average Grant Date Fair Value
Outstanding as of March 31, 2023 | 557 |  |  | $ | 130.03 |
Granted | 682 |  |  | 128.66 |
Vested | (73) |  |  | 127.98 |
Forfeited or cancelled | (330) |  |  | 128.74 |
Outstanding as of December 31, 2023 | 836 |  |  | $ | 129.60 |
The following table summarizes our market-based restricted stock unit activity, presented with the maximum number of shares that could potentially vest, for the nine months ended December 31, 2023:
| Market-Based Restricted Stock Units (in thousands) |  | Weighted- Average Grant Date Fair Value
Outstanding as of March 31, 2023 | 822 |  |  | $ | 149.98 |
Granted | 143 |  |  | 152.92 |
Vested | (50) |  |  | 125.62 |
Forfeited or cancelled | (561) |  |  | 141.20 |
Outstanding as of December 31, 2023 | 354 |  |  | $ | 168.53 |
The following table summarizes stock-based compensation expense resulting from stock options, restricted stock units, market-based restricted stock units, performance-based restricted stock units, and the ESPP purchase rights included in our Condensed Consolidated Statements of Operations (in millions):
| Three Months Ended December 31, |  | Nine Months Ended December 31,
| 2023 |  | 2022 |  | 2023 |  | 2022
Cost of revenue | $ | 2 |  |  | $ | 2 |  |  | $ | 6 |  |  | $ | 5 |
Research and development | 108 |  |  | 95 |  |  | 314 |  |  | 271 |
Marketing and sales | 14 |  |  | 15 |  |  | 38 |  |  | 44 |
General and administrative | 27 |  |  | 29 |  |  | 78 |  |  | 86 |
Stock-based compensation expense | $ | 151 |  |  | $ | 141 |  |  | $ | 436 |  |  | $ | 406 |

X
- Definition Tabular disclosure of share-based payment arrangement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 1 -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-1 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for repurchase agreements. + References No definition available. + Details
Name: | us-gaap_ScheduleOfRepurchaseAgreements
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration